Mira Pharmaceuticals (MIRA) Enterprise Value (2022 - 2025)
Mira Pharmaceuticals (MIRA) posted Enterprise Value of -$11.0 million for Q4 2025, down 46.37% sequentially from -$7.5 million in Q3 2025, and down 289.35% YoY from $5.8 million in Q4 2024.
Mira Pharmaceuticals (MIRA) Enterprise Value (2022 - 2025) Analysis & Trends
Mira Pharmaceuticals (MIRA) has 4 years of Enterprise Value data on file, last reported at -$11.0 million in Q4 2025.
- Quarterly Enterprise Value fell 289.35% year-over-year to -$11.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$11.0 million (down 289.35% YoY) and the FY2025 annual result came in at -$11.0 million, down 289.35% from the prior year.
- Enterprise Value declined to -$11.0 million in Q4 2025 per MIRA's latest filing, from -$7.5 million in the prior quarter.
- The five-year high for Enterprise Value was -$1349.0 in Q1 2023, with the low at -$11.0 million in Q4 2025.
- Average Enterprise Value over 4 years is -$3.2 million, with a median of -$2.8 million recorded in 2024.
- Year-over-year, Enterprise Value plunged 259351.45% in 2024 and jumped 65.53% in 2025.
- Mira Pharmaceuticals' Enterprise Value stood at -$350978.0 in 2022, then sank by 1211.35% to -$4.6 million in 2023, then soared by 38.45% to -$2.8 million in 2024, then slumped by 289.35% to -$11.0 million in 2025.
- Business Quant data shows MIRA's Enterprise Value at -$11.0 million in Q4 2025, -$7.5 million in Q3 2025, and -$730475.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | -5.28 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | -22.05 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | -9.35 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -7.89 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -5.65 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | -12.04 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | -7.73 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | -12.77 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | 315.00 Mn |
| 10 | Mira Pharmaceuticals | 22.51 Mn | 11.48 Mn | - | -11.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.03 Mn |
| Sep 30, 2025 | -7.54 Mn |
| Jun 30, 2025 | -730,475.00 |
| Mar 31, 2025 | -1.21 Mn |
| Dec 31, 2024 | -2.83 Mn |
| Sep 30, 2024 | -4.10 Mn |
| Mar 31, 2024 | -3.50 Mn |
| Dec 31, 2023 | -4.60 Mn |
| Sep 30, 2023 | -5.87 Mn |
| Jun 30, 2023 | -24,823.00 |
| Mar 31, 2023 | -1,349.00 |
| Dec 31, 2022 | -350,978.00 |
| Sep 30, 2022 | -187,415.00 |